Folliculotropic Mycosis Fungoides Treatment Market - Global Outlook and Forecast 2021-2027

March 2021 | 90 pages | ID: FD9B8F838AE6EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Folliculotropic Mycosis Fungoides Treatment in Global, including the following market information:

Global Folliculotropic Mycosis Fungoides Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Folliculotropic Mycosis Fungoides Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Folliculotropic Mycosis Fungoides Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Folliculotropic Mycosis Fungoides Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Folliculotropic Mycosis Fungoides Treatment Market Segment Percentages, By Type, 2020 (%)

• Small Molecule
• Biologics

China Folliculotropic Mycosis Fungoides Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Folliculotropic Mycosis Fungoides Treatment Market Segment Percentages, By Application, 2020 (%)

• Hospital
• Specialty Clinic
• Others

Global Folliculotropic Mycosis Fungoides Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Folliculotropic Mycosis Fungoides Treatment Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Folliculotropic Mycosis Fungoides Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Folliculotropic Mycosis Fungoides Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Takeda Pharmaceutical Company
• Merck
• Seattle Genetics
• Kyowa Kirin
• Eisai
• Helsinn Healthcare
• Horizon Therapeutics
• Celegene Corporation
• Azurity Pharmaceuticals
• Elorac
• Soligenix
• Actelion Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Folliculotropic Mycosis Fungoides Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Folliculotropic Mycosis Fungoides Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL FOLLICULOTROPIC MYCOSIS FUNGOIDES TREATMENT OVERALL MARKET SIZE

2.1 Global Folliculotropic Mycosis Fungoides Treatment Market Size: 2021 VS 2027
2.2 Global Folliculotropic Mycosis Fungoides Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Folliculotropic Mycosis Fungoides Treatment Players in Global Market
3.2 Top Global Folliculotropic Mycosis Fungoides Treatment Companies Ranked by Revenue
3.3 Global Folliculotropic Mycosis Fungoides Treatment Revenue by Companies
3.4 Top 3 and Top 5 Folliculotropic Mycosis Fungoides Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Folliculotropic Mycosis Fungoides Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Folliculotropic Mycosis Fungoides Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Folliculotropic Mycosis Fungoides Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Folliculotropic Mycosis Fungoides Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Folliculotropic Mycosis Fungoides Treatment Market Size Markets, 2021 & 2027
  4.1.2 Small Molecule
  4.1.3 Biologics
4.2 By Type - Global Folliculotropic Mycosis Fungoides Treatment Revenue & Forecasts
  4.2.1 By Type - Global Folliculotropic Mycosis Fungoides Treatment Revenue, 2016-2021
  4.2.2 By Type - Global Folliculotropic Mycosis Fungoides Treatment Revenue, 2022-2027
  4.2.3 By Type - Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Folliculotropic Mycosis Fungoides Treatment Market Size, 2021 & 2027
  5.1.2 Hospital
  5.1.3 Specialty Clinic
  5.1.4 Others
5.2 By Application - Global Folliculotropic Mycosis Fungoides Treatment Revenue & Forecasts
  5.2.1 By Application - Global Folliculotropic Mycosis Fungoides Treatment Revenue, 2016-2021
  5.2.2 By Application - Global Folliculotropic Mycosis Fungoides Treatment Revenue, 2022-2027
  5.2.3 By Application - Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Folliculotropic Mycosis Fungoides Treatment Market Size, 2021 & 2027
6.2 By Region - Global Folliculotropic Mycosis Fungoides Treatment Revenue & Forecasts
  6.2.1 By Region - Global Folliculotropic Mycosis Fungoides Treatment Revenue, 2016-2021
  6.2.2 By Region - Global Folliculotropic Mycosis Fungoides Treatment Revenue, 2022-2027
  6.2.3 By Region - Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Folliculotropic Mycosis Fungoides Treatment Revenue, 2016-2027
  6.3.2 US Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027
  6.3.3 Canada Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027
  6.3.4 Mexico Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Folliculotropic Mycosis Fungoides Treatment Revenue, 2016-2027
  6.4.2 Germany Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027
  6.4.3 France Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027
  6.4.4 U.K. Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027
  6.4.5 Italy Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027
  6.4.6 Russia Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027
  6.4.7 Nordic Countries Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027
  6.4.8 Benelux Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Folliculotropic Mycosis Fungoides Treatment Revenue, 2016-2027
  6.5.2 China Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027
  6.5.3 Japan Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027
  6.5.4 South Korea Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027
  6.5.5 Southeast Asia Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027
  6.5.6 India Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Folliculotropic Mycosis Fungoides Treatment Revenue, 2016-2027
  6.6.2 Brazil Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027
  6.6.3 Argentina Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Revenue, 2016-2027
  6.7.2 Turkey Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027
  6.7.3 Israel Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027
  6.7.4 Saudi Arabia Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027
  6.7.5 UAE Folliculotropic Mycosis Fungoides Treatment Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Takeda Pharmaceutical Company
  7.1.1 Takeda Pharmaceutical Company Corporate Summary
  7.1.2 Takeda Pharmaceutical Company Business Overview
  7.1.3 Takeda Pharmaceutical Company Folliculotropic Mycosis Fungoides Treatment Major Product Offerings
  7.1.4 Takeda Pharmaceutical Company Folliculotropic Mycosis Fungoides Treatment Revenue in Global (2016-2021)
  7.1.5 Takeda Pharmaceutical Company Key News
7.2 Merck
  7.2.1 Merck Corporate Summary
  7.2.2 Merck Business Overview
  7.2.3 Merck Folliculotropic Mycosis Fungoides Treatment Major Product Offerings
  7.2.4 Merck Folliculotropic Mycosis Fungoides Treatment Revenue in Global (2016-2021)
  7.2.5 Merck Key News
7.3 Seattle Genetics
  7.3.1 Seattle Genetics Corporate Summary
  7.3.2 Seattle Genetics Business Overview
  7.3.3 Seattle Genetics Folliculotropic Mycosis Fungoides Treatment Major Product Offerings
  7.3.4 Seattle Genetics Folliculotropic Mycosis Fungoides Treatment Revenue in Global (2016-2021)
  7.3.5 Seattle Genetics Key News
7.4 Kyowa Kirin
  7.4.1 Kyowa Kirin Corporate Summary
  7.4.2 Kyowa Kirin Business Overview
  7.4.3 Kyowa Kirin Folliculotropic Mycosis Fungoides Treatment Major Product Offerings
  7.4.4 Kyowa Kirin Folliculotropic Mycosis Fungoides Treatment Revenue in Global (2016-2021)
  7.4.5 Kyowa Kirin Key News
7.5 Eisai
  7.5.1 Eisai Corporate Summary
  7.5.2 Eisai Business Overview
  7.5.3 Eisai Folliculotropic Mycosis Fungoides Treatment Major Product Offerings
  7.5.4 Eisai Folliculotropic Mycosis Fungoides Treatment Revenue in Global (2016-2021)
  7.5.5 Eisai Key News
7.6 Helsinn Healthcare
  7.6.1 Helsinn Healthcare Corporate Summary
  7.6.2 Helsinn Healthcare Business Overview
  7.6.3 Helsinn Healthcare Folliculotropic Mycosis Fungoides Treatment Major Product Offerings
  7.6.4 Helsinn Healthcare Folliculotropic Mycosis Fungoides Treatment Revenue in Global (2016-2021)
  7.6.5 Helsinn Healthcare Key News
7.7 Horizon Therapeutics
  7.7.1 Horizon Therapeutics Corporate Summary
  7.7.2 Horizon Therapeutics Business Overview
  7.7.3 Horizon Therapeutics Folliculotropic Mycosis Fungoides Treatment Major Product Offerings
  7.4.4 Horizon Therapeutics Folliculotropic Mycosis Fungoides Treatment Revenue in Global (2016-2021)
  7.7.5 Horizon Therapeutics Key News
7.8 Celegene Corporation
  7.8.1 Celegene Corporation Corporate Summary
  7.8.2 Celegene Corporation Business Overview
  7.8.3 Celegene Corporation Folliculotropic Mycosis Fungoides Treatment Major Product Offerings
  7.8.4 Celegene Corporation Folliculotropic Mycosis Fungoides Treatment Revenue in Global (2016-2021)
  7.8.5 Celegene Corporation Key News
7.9 Azurity Pharmaceuticals
  7.9.1 Azurity Pharmaceuticals Corporate Summary
  7.9.2 Azurity Pharmaceuticals Business Overview
  7.9.3 Azurity Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Major Product Offerings
  7.9.4 Azurity Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Revenue in Global (2016-2021)
  7.9.5 Azurity Pharmaceuticals Key News
7.10 Elorac
  7.10.1 Elorac Corporate Summary
  7.10.2 Elorac Business Overview
  7.10.3 Elorac Folliculotropic Mycosis Fungoides Treatment Major Product Offerings
  7.10.4 Elorac Folliculotropic Mycosis Fungoides Treatment Revenue in Global (2016-2021)
  7.10.5 Elorac Key News
7.11 Soligenix
  7.11.1 Soligenix Corporate Summary
  7.11.2 Soligenix Business Overview
  7.11.3 Soligenix Folliculotropic Mycosis Fungoides Treatment Major Product Offerings
  7.11.4 Soligenix Folliculotropic Mycosis Fungoides Treatment Revenue in Global (2016-2021)
  7.11.5 Soligenix Key News
7.12 Actelion Pharmaceuticals
  7.12.1 Actelion Pharmaceuticals Corporate Summary
  7.12.2 Actelion Pharmaceuticals Business Overview
  7.12.3 Actelion Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Major Product Offerings
  7.12.4 Actelion Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Revenue in Global (2016-2021)
  7.12.5 Actelion Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Folliculotropic Mycosis Fungoides Treatment Market Opportunities & Trends in Global Market
Table 2. Folliculotropic Mycosis Fungoides Treatment Market Drivers in Global Market
Table 3. Folliculotropic Mycosis Fungoides Treatment Market Restraints in Global Market
Table 4. Key Players of Folliculotropic Mycosis Fungoides Treatment in Global Market
Table 5. Top Folliculotropic Mycosis Fungoides Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Folliculotropic Mycosis Fungoides Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Folliculotropic Mycosis Fungoides Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Folliculotropic Mycosis Fungoides Treatment Product Type
Table 9. List of Global Tier 1 Folliculotropic Mycosis Fungoides Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Folliculotropic Mycosis Fungoides Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Folliculotropic Mycosis Fungoides Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Folliculotropic Mycosis Fungoides Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Folliculotropic Mycosis Fungoides Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Folliculotropic Mycosis Fungoides Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Folliculotropic Mycosis Fungoides Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Folliculotropic Mycosis Fungoides Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Takeda Pharmaceutical Company Corporate Summary
Table 31. Takeda Pharmaceutical Company Folliculotropic Mycosis Fungoides Treatment Product Offerings
Table 32. Takeda Pharmaceutical Company Folliculotropic Mycosis Fungoides Treatment Revenue (US$, Mn), (2016-2021)
Table 33. Merck Corporate Summary
Table 34. Merck Folliculotropic Mycosis Fungoides Treatment Product Offerings
Table 35. Merck Folliculotropic Mycosis Fungoides Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Seattle Genetics Corporate Summary
Table 37. Seattle Genetics Folliculotropic Mycosis Fungoides Treatment Product Offerings
Table 38. Seattle Genetics Folliculotropic Mycosis Fungoides Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Kyowa Kirin Corporate Summary
Table 40. Kyowa Kirin Folliculotropic Mycosis Fungoides Treatment Product Offerings
Table 41. Kyowa Kirin Folliculotropic Mycosis Fungoides Treatment Revenue (US$, Mn), (2016-2021)
Table 42. Eisai Corporate Summary
Table 43. Eisai Folliculotropic Mycosis Fungoides Treatment Product Offerings
Table 44. Eisai Folliculotropic Mycosis Fungoides Treatment Revenue (US$, Mn), (2016-2021)
Table 45. Helsinn Healthcare Corporate Summary
Table 46. Helsinn Healthcare Folliculotropic Mycosis Fungoides Treatment Product Offerings
Table 47. Helsinn Healthcare Folliculotropic Mycosis Fungoides Treatment Revenue (US$, Mn), (2016-2021)
Table 48. Horizon Therapeutics Corporate Summary
Table 49. Horizon Therapeutics Folliculotropic Mycosis Fungoides Treatment Product Offerings
Table 50. Horizon Therapeutics Folliculotropic Mycosis Fungoides Treatment Revenue (US$, Mn), (2016-2021)
Table 51. Celegene Corporation Corporate Summary
Table 52. Celegene Corporation Folliculotropic Mycosis Fungoides Treatment Product Offerings
Table 53. Celegene Corporation Folliculotropic Mycosis Fungoides Treatment Revenue (US$, Mn), (2016-2021)
Table 54. Azurity Pharmaceuticals Corporate Summary
Table 55. Azurity Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Product Offerings
Table 56. Azurity Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Revenue (US$, Mn), (2016-2021)
Table 57. Elorac Corporate Summary
Table 58. Elorac Folliculotropic Mycosis Fungoides Treatment Product Offerings
Table 59. Elorac Folliculotropic Mycosis Fungoides Treatment Revenue (US$, Mn), (2016-2021)
Table 60. Soligenix Corporate Summary
Table 61. Soligenix Folliculotropic Mycosis Fungoides Treatment Product Offerings
Table 62. Soligenix Folliculotropic Mycosis Fungoides Treatment Revenue (US$, Mn), (2016-2021)
Table 63. Actelion Pharmaceuticals Corporate Summary
Table 64. Actelion Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Product Offerings
Table 65. Actelion Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Folliculotropic Mycosis Fungoides Treatment Segment by Type
Figure 2. Folliculotropic Mycosis Fungoides Treatment Segment by Application
Figure 3. Global Folliculotropic Mycosis Fungoides Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Folliculotropic Mycosis Fungoides Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Folliculotropic Mycosis Fungoides Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Folliculotropic Mycosis Fungoides Treatment Revenue in 2020
Figure 8. By Type - Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Folliculotropic Mycosis Fungoides Treatment Revenue Market Share, 2016-2027
Figure 12. US Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Folliculotropic Mycosis Fungoides Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Folliculotropic Mycosis Fungoides Treatment Revenue Market Share, 2016-2027
Figure 24. China Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Folliculotropic Mycosis Fungoides Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Folliculotropic Mycosis Fungoides Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Takeda Pharmaceutical Company Folliculotropic Mycosis Fungoides Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Merck Folliculotropic Mycosis Fungoides Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Seattle Genetics Folliculotropic Mycosis Fungoides Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Kyowa Kirin Folliculotropic Mycosis Fungoides Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Eisai Folliculotropic Mycosis Fungoides Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Helsinn Healthcare Folliculotropic Mycosis Fungoides Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Horizon Therapeutics Folliculotropic Mycosis Fungoides Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Celegene Corporation Folliculotropic Mycosis Fungoides Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Azurity Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Elorac Folliculotropic Mycosis Fungoides Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Soligenix Folliculotropic Mycosis Fungoides Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Actelion Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)